SynthesisJournal of comparative effectiveness research2024

Comparing the efficacy of cipaglucosidase alfa plus miglustat with other enzyme replacement therapies for late-onset Pompe disease: a network meta-analysis utilizing patient-level and aggregate data.

Simon Shohet et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.